The Genetic Information Nondiscrimination Act of 2008 (GINA) is a federal law that protects individuals from genetic discrimination in health insurance and employment. This resource provides an introduction to the Genetic Information Nondiscrimination Act and its protections in health insurance and employment. It includes answers to common questions about GINA and examples to help patients learn.
The Food and Drug Administration, which monitors the safety of all drugs in the United States, has included pharmacogenomic information on the labels of more than 150 medications. This information, which includes dosage guidance, possible side effects or differences in effectiveness for people with certain genomic variations, can help doctors tailor their drug prescriptions for individual patients.
The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships. PharmGKB collects, curates and disseminates knowledge about the impact of human genetic variation on drug responses.